arBtrage CAPITALIZING MARKETS checking… Sign in

Opus Genetics, Inc.

IRD Health Care Biotechnology: Pharmaceutical Preparations
$4.03
▼ -13.2% Today
as of Jun 7, 07:18 ET
Last 30 days -19.40% Apr 28 → Jun 05
$3.88 $4.28 $4.68 $5.07 $5.47 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.61
High
$4.61
Low
$4.01
Volume
$1M
Avg Vol
$642,482
Mkt Cap
$342M
P/E (TTM)
Beta
52w High
$5.81
52w Low
$0.90
Div Yield
Shares Out
$71M

Overview

52-week range
$0.90
$5.81
64% of range
Avg surprise (last 2)
-181.4%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
81%
EM ±11.2% · $5 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.75$-0.50$-0.25$0.00$0.25 Actual $-0.24Actual $0.25Actual $-0.29Actual $-0.30Actual $-0.29Actual $-0.32Est $-0.34Actual $-0.12Actual $-0.25Actual $-0.75Est $-0.16 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-66M$-51M$-37M$-22M$-8M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.75 $-0.16 -368.8% -134.4% +1.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.25 financials
Mon Jun 30, 2025Jun 2025 $-0.12 financials
Thu May 15, 2025Mar/2025 $-0.32 $-0.34 +5.9% 0.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.29 financials
Sun Jun 30, 2024Jun 2024 $-0.30 financials
Sun Mar 31, 2024Mar 2024 $-0.29 financials
Sat Sep 30, 2023Sep 2023 $0.25 financials
Fri Jun 30, 2023Jun 2023 $-0.24 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-14M$-8M$-9M$-10M$-8M$-8M
Net income$-66M$-17M$-7M$-8M$-8M$-8M
EPS (diluted)$-0.75$-0.25$-0.12$-0.24$-0.29$-0.30

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$60M$45M$31M$32M$42M$30M$37M$41M
Inventory
Total current assets$67M$50M$36M$38M$48M$37M$40M$45M
Total assets$67M$50M$36M$39M$48M$37M$40M$45M
Long-term debt$1M$1M$1M$1M$0
Total liabilities$88M$35M$30M$21M$24M$11M$6M$4M
Total equity$-46M$15M$6M$17M$5M$7M$34M$41M

Implied volatility — last 90 days

75%78%80%83%85% Jun 07 — IV 81% · EM ±11.2%

Sector peers